Insider buying
~$11K2,900 sh @ $3.76
Traded Apr 22 · filed 1 day later
The CEO of Nasus Pharma paid $11K out of pocket for Nasus Pharma shares.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Among this manager's largest new positions for Q1 2026. From a 13F filed May 15, 2026 covering holdings at Mar 31, 2026 — a quarter-end snapshot, not a live trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
New
Compared with the manager's Q4 2025 13F
601,998
0.56%
Within the filing's reported positions, not the manager's total assets
1
For Q1 2026
Insider buying
Traded Apr 22 · filed 1 day later
The CEO of Nasus Pharma paid $11K out of pocket for Nasus Pharma shares.
Insider buying
Traded Mar 31 · filed 1 day later
The CEO of Nasus Pharma paid $31K out of pocket for Nasus Pharma shares. Shares held went up 240% with this purchase.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.